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A new type III polyketide synthase gene (Ssars) was discovered from the genome of 22 
Shiraia sp. Slf14, an endophytic fungal strain from Huperzia serrata. The intron-free 23 
gene was cloned from the cDNA and ligated to two expression vectors pET28a and 24 
YEpADH2p-URA3 for expression in Escherichia coli BL21(DE3) and Saccharomyces 25 
cerevisiae BJ5464, respectively. SsARS was efficiently expressed in E. coli BL21(DE3), 26 
leading to the synthesis of a series of polyketide products. Six major products were 27 
isolated from the engineered E. coli and characterized as 1,3-dihydroxyphenyl-5-28 
undecane, 1,3-dihydroxyphenyl-5-cis-6'-tridecene,1,3-dihydroxyphenyl-5-tridecane, 29 
1,3-dihydroxyphenyl-5-cis-8'-pentadecene, 1,3-dihydroxyphenyl-5-pentadecane and 30 
1,3-dihydroxyphenyl-5-cis-10'-heptadecene, respectively, based on the spectral data 31 
and biosynthetic origin. Expression of SsARS in the yeast also led to the synthesis of 32 
the same polyketide products, indicating that this enzyme can be reconstituted in both 33 
heterologous hosts. Supplementation of soybean oil into the culture of E. coli 34 
BL21(DE3)/SsARS increased the production titers of 1-6 and led to the synthesis of an 35 
additional product, which was identified as 5-(8'Z,11'Z-heptadecadienyl)resorcinol. 36 
This work thus allowed the identification of SsARS as a 5-alk(en)ylresorcinol synthase 37 
with flexible substrate specificity toward endogenous and exogenous fatty acids. 38 
Desired resorcinol derivatives may be synthesized by supplying corresponding fatty 39 
acids into the culture medium.    40 
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Fungi are known to produce a large variety of bioactive natural products, such as 44 
lovastatin (anti-cholesterol) and penicillin (antibacterial). Polyketides are a large family 45 
of structurally diverse natural products including erythromycin (antibacterial), 46 
tetracycline (antibacterial) and doxorubicin (antitumor). They are assembled from acyl-47 
coenzyme A precursors by polyketide synthases (PKSs), which are classified into three 48 
groups based on sequences and functional mechanisms, including types I, II, and III. 49 
Type I PKS, similar to type I fatty acid synthase (FAS), is a giant assembly of 50 
multifunctional polypeptides, each consisting of a series of catalytic domains 51 
(Keatinge-Clay 2012). Representative bioactive compounds synthesized by type I PKSs 52 
are lovastatin and erythromycin. Type II PKSs are discrete enzymes that work 53 
collaboratively to form aromatic polyketide products, such as tetracycline and 54 
doxorubicin (Zhan 2009). Type III PKSs are self-contained enzymes that form 55 
homodimers. These single enzymes can catalyze precursor priming, chain extension 56 
and cyclization. Type III PKSs are involved in the biosynthesis of a wide array of 57 
natural products such as chalcones, pyrones, acridones, phloroglucinols, stilbenes, and 58 
resorcinolic lipids (Yu et al. 2012). All three types of PKS are present in bacteria and 59 
type II PKSs are exclusively found in bacteria such as actinomycetes. Plants contain 60 
various type III PKSs, while fungi are known to harbor type I and type III PKSs. These 61 
PKSs are involved in the formation of various metabolites in these hosts.  62 
Alk(en)ylresorcinols are phenolic lipids synthesized by type III PKSs. They are 63 
commonly present in several plant families and have been proposed as specific dietary 64 
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biomarkers of whole-grain wheat and rye intake (Kyro et al. 2014; Landberg et al. 2008). 65 
They were also found in fungi, algae, mosses, bacteria, and marine sponges (Landberg 66 
et al. 2014). Many of natural alk(en)ylresorcinols have shown antimicrobial activities. 67 
For example, DB-2017 is an alkylresorcinol antibiotic from Pseudomonas sp. B-9094. 68 
It has shown antimicrobial activity against mycobacteria, Gram-positive bacteria, and 69 
fungi (Kanda et al. 1975; Kitahara and Kanda 1975). Some resorcinol derivatives were 70 
also found to possess cytotoxic, anticarcinogenic, antiproliferative, antileishmanial and 71 
antioxidant properties (Luis et al. 2016).  72 
Symbiotic microorganisms in plants live closely with the hosts and are found to 73 
produce various valuable compounds. Shiraia sp. Slf14 is a promising endophytic 74 
fungus from Huperzia serrata. This strain possesses the ability to produce hypocrellins 75 
and huperzine A (Yang et al. 2014). As polyketide natural products, hypocrellins are a 76 
group of molecules with a good prospect of clinical applications, and have been used 77 
as an effective photosensitizer for photodynamic therapy (PDT) of tumors (Ali and 78 
Olivo 2002; Ali et al. 2001; Estey et al. 1996). Huperzine A is a sesquiterpene alkaloid 79 
originally isolated from H. serrata. It acts as a cholinesterase inhibitor and thus has 80 
potential for use in the treatment of Alzheimer’s disease (Damar et al. 2017). 81 
To better understand Shiraia sp. Slf14, we have sequenced the genome of this 82 
fungus (Yang et al. 2014). Analysis of the sequence genome revealed a putative type III 83 
PKS. Here we report the identification of this type III PKS and heterologous 84 
reconstitution of this enzyme in Escherichia coli and Saccharomyces cerevisiae. Six 85 
alk(en)ylresorcinols were synthesized by this enzyme from malonyl-CoA and various 86 
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fatty acyl starter units. An additional alkylresorcinol was generated by E. coli when 87 
soybean oil was supplemented into the medium.  88 
Materials and Methods 89 
Strains and media 90 
DNA manipulations were performed using standard techniques with E. coli XL1-Blue 91 
as a host organism. Expression vector pET28a was purchased from Novagen (Madison, 92 
WI, USA). E. coli BL21(DE3) purchased from Stratagene (La Jolla, CA, USA) was 93 
used as the expression host. The E. coli strains were routinely grown in LB medium. 94 
Shiraia sp. Slf14 (CCTCC No. M209294) was previously isolated from H. serrata and 95 
was grown in potato dextrose broth (PDB) medium (Zhu et al. 2010). S. cerevisiae 96 
BJ5464 (ATCC 208288) was obtained from the American Type Culture Collection and 97 
routinely grown in YPD medium. 98 
Construction of pET28a-Ssars (pHW4) and YEpADH2p-URA3-Ssars (pHW8) 99 
Wild type Shiraia sp. Slf14 was grown in PDB for 3 days. The cells were harvested by 100 
filtration, from which the RNA was extracted with TRIzol Reagent (Invitrogen, USA). 101 
The extracted RNA was purified with a Direct-zol RNA MiniPrep kit (Zymo Research, 102 
CA, USA). The cDNA was synthesized from mRNA with M-MuLV Reverse 103 
Transcriptase (NEB, MA, USA). With the cDNA as a template, the 1,278-bp DNA 104 
intron-free Ssars gene (GenBank accession no. MH048853) was amplified by PCR with 105 
a set of specific primers including SsARS-F-NheI (5'- 106 
aaGCTAGCatgtcccacgtggctaacac-3', with a NheI site shown by underlining) and 107 
SsARS-R-BamHI (5'-aaGGATCCttaacctgttcgtacagtgt-3', with an BamHI site shown by 108 
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underlining). The resulting PCR product was cloned into the pJET1.2 cloning vector. 109 
After sequencing, this gene subsequently cloned into the pET28a vector between the 110 
NheI and BamHI sites, yielding pHW4. The same gene was amplified by PCR using 111 
another primer set including the above mentioned SsARS-F-NheI and SsARS-R-PmeI 112 
(5'-aaGTTTAAACttaacctgttcgtacagtgt-3', with a PmeI site shown by underlining). The 113 
resulting PCR product was cloned into pJET1.2, and subsequently inserted into the 114 
yeast expression vector YEpADH2p-URA3 between the NheI and PmeI sites, yielding 115 
pHW8.     116 
SDS-PAGE analysis of the expression of SsARS in E. coli BL21(DE3) 117 
E. coli BL21(DE3)/pHW4 was grown in 50 mL of LB medium supplemented with 50 118 
µg/mL kanamycin at 37°C to a certain OD600 0.4-0.6. The culture was then induced by 119 
200 µM isopropyl-1-thio-β-D-galactoside (IPTG) and incubated at 28℃ and 250 rpm 120 
for 12 hrs. Cells were harvested by centrifugation at 4,000 rpm for 10 min, resuspended 121 
in the lysis buffer composed of 20 mM Tris–HCl (pH 7.9) and 0.5 M NaCl, and 122 
disrupted by sonication. A crude cell lysate was prepared by removal of cell debris by 123 
centrifugation at 13,000 rpm at 4 °C for 15 min, which was then analyzed by SDS-124 
PAGE. 125 
LC-MS analysis of the polyketide products in E. coli BL21I(DE3)/pHW4 126 
For production analysis, E. coli BL21I(DE3)/pHW4 was grown and induced as 127 
described above. The pellet was extracted with methanol and the supernatant with an 128 
equal volume of ethyl acetate three times. The extracts were combined and analyzed on 129 
an Agilent 1200 HPLC instrument (Agilent Eclipse Plus C18, 5 μm, 4.6 mm × 250 mm) 130 
7 
 
connected with an Agilent 6130 Single Quadrupole mass spectrometer, eluted with a 131 
linear gradient of 75 to 90 % (v/v) acetonitrile-water (containing 0.1% trifluoroacetic 132 
acid) over 45 min at a flow rate of 1 mL/min. The products were detected at 210 nm.      133 
Purification and structural characterization of alk(en)ylresorcinols 1–6 134 
To isolate compounds 1–6 for structural characterization, the culture of E. coli 135 
BL21(DE3)/pHW4 was scaled up to 200 mL. Briefly, 200 µL of seed culture 136 
(OD600=1.0) of E. coli BL21(DE3)/pHW4 was inoculated into 200 mL of LB medium 137 
containing 50 μg/mL kanamycin, and grown to OD600 of 1.0. 200 µM IPTG was then 138 
added to induce protein expression. After an additional 72 hrs, the culture was extracted 139 
as described above. To isolate these compounds, a typical purification procedure was 140 
given below. The crude extract was fractionated on a silica gel-60 column, eluted with 141 
a stepwise gradient of ethyl acetate-hexane (0:100, 1:99, 2:98, 3:97, 5:95, 10:90, 15:85, 142 
20:80 v/v, each 250 mL) to afford 8 fractions. The fractions containing the target 143 
compounds were further separated by reverse-phased HPLC (Agilent Eclipse Plus C18, 144 
5 μm, 4.6×250 mm), eluted with acetonitrile-water at a flow rate of 1 mL/min. 145 
Compounds 1 and 2 were found to be in fraction 6 after silica gel column 146 
chromatography. This fraction was further separated on HPLC with 67% acetonitrile-147 
water. The peaks at 20.5 min and 23.7 min were collected to yield 1.7 mg of 1 and 1.4 148 
mg of 2 in pure form. Compounds 3 and 4 were found to be in fraction 5 after silica gel 149 
column chromatography. This fraction was further separated on HPLC with 74% 150 
acetonitrile-water. The peaks at 32.4 min and 35.6 min were collected to yield 1.5 mg 151 
of 3 and 2.1 mg of 4, respectively, in pure form. Compounds 5 and 6 were found to be 152 
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in fraction 3 after silica gel column chromatography. This fraction was further separated 153 
on HPLC with 82% acetonitrile-water. The peaks at 47.9 min and 50.5 min were 154 
collected to yield 0.9 mg of 5 and 1.2 mg of 6, respectively. Electrospray ionization 155 
mass spectrometry (ESI-MS) spectra were collected on an Agilent 6130 Single 156 
quadrupole LC-MS. Nuclear magnetic resonance (NMR) spectra were acquired in 157 
CDCl3 on a Bruker NMR instrument (500 MHz for 
1H NMR). The chemical shift (δ) 158 
values were given in parts per million (ppm). The coupling constants (J values) were 159 
reported in Hertz (Hz). 160 
Compound 1: ESI-MS (+): [M+H]+ m/z 265.2; lH NMR (500 MHz, CDC13): δ 6.26 161 
(2H, d, J = 1.8 Hz, H-4 and H-6), 6.22 (1H, t, J = 1.8 Hz, H-2), 2.49 (2H, t, J = 7.5 Hz, 162 
H-1'), 1.58 (2H, m, H-2'), 1.27 (approx. 16H, brs), 0.90 (3H. t, J = 6.9 Hz, H-11').   163 
Compound 2: ESI-MS (+): [M+H]+ m/z 291.2; lH NMR (500 MHz, CDC13): δ 6.26 164 
(2H, d, J = 1.8 Hz, H-4 and H-6), 6.20 (1H, t, J = 1.8 Hz, H-2), 5.38-5.36 (2H, m, H-6' 165 
and H-7'), 2.51 (2H, t, J = 7.5 Hz, H-1'), 2.02 (4H, m, H-5' and H-8'), 1.59 (2H, m, H-166 
2'), 1.34 (approx. 12H, brs), 0.92 (3H. t, J = 6.9 Hz, H-13').  167 
Compound 3: ESI-MS (+): [M+H]+ m/z 293.2; lH NMR (500 MHz, CDC13): δ 6.26 168 
(2H, d, J = 1.8 Hz, H-4 and H-6), 6.20 (1H, t, J = 1.8 Hz, H-2), 2.49 (2H, t, J = 7.5 Hz, 169 
H-1'), 1.59 (2H, m, H-2'), 1.32 (approx. 20H, brs), 0.91 (3H. t, J = 6.9 Hz, H-13').  170 
Compound 4: ESI-MS (+): [M+H]+ m/z 319.2; lH NMR (500 MHz, CDC13): δ 6.27 171 
(2H, d, J = 1.8Hz, H-4 and H-6), 6.21 (1H, t, J = 1.8 Hz, H-2), 5.38-5.36 (2H, m, H-8' 172 
and H-9'), 2.49 (2H, t, J = 7.5 Hz, H-1'), 2.03 (4H, m, H-7' and H-10'), 1.59 (2H, m, H-173 
2'), 1.29 (approx. 16H, brs), 0.89 (3H, t, J = 6.9 Hz, H-15').  174 
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Compound 5: ESI-MS (+): [M+H]+ m/z 321.4; lH NMR (500 MHz, CDC13): δ 6.26 175 
(2H, d, J = 1.8 Hz, H-4 and H-6), 6.19 (1H, t, J = 1.8 Hz, H-2), 2.51 (2H, t, J = 7.5 Hz, 176 
H-1'), 1.59 (2H, m, H-2'), 1.28 (approx. 24H, brs), 0.90 (3H, t, J = 6.9 Hz, H-15').  177 
Compound 6: ESI-MS (+): [M+H]+ m/z 347.3; lH NMR (500 MHz, CDC13): δ 6.26 178 
(2H, d, J = 1.8 Hz, H-4 and H-6), 6.20 (1H, t, J = 1.8 Hz, H-2), 5.37-5.36 (2H, m, H-179 
10' and H-11'), 2.50 (2H, t, J = 7.5 Hz, H-1'), 2.03 (4H, m, H-9' and H-12'), 1.57 (2H, 180 
m, H-2'), 1.34 (approx. 20H, brs), 0.89 (3H, t, J = 6.9 Hz, H-17').  181 
Supplementation of soybean oil into the fermentation broth of E. coli 182 
BL21(DE3)/pHW4 183 
E. coli BL21(DE3)/pHW4 was grown in 50 mL of LB with 50 μg/mL kanamycin and 184 
induced by IPTG as described above except that 20 g/L soybean oil was supplied into 185 
the broth. The culture was extracted and analyzed by LC-MS as described above. 186 
To isolate 7, E. coli BL21(DE3)/pHW4 was grown in 200 mL of LB with 50 μg/mL 187 
kanamycin and 20 g/L soybean oil. After fermentation, the broth was extracted and 188 
separated as described above. Compound 7 was found to be in fraction 5 after silica gel 189 
column chromatography. This fraction was further separated on HPLC with 74% 190 
acetonitrile-water. The peak at 30.7 min was collected to yield 2.1 mg of 7 in pure form. 191 
Compound 7: ESI-MS (+): [M+H]+ m/z 345.3; lH NMR (500 MHz, CDC13): δ 6.25 192 
(2H, d, J = 1.8 Hz, H-4 and H-6), 6.20 (1H, t, J = 1.8 Hz, H-2), 5.34-5.41 (4H, m, H-8', 193 
H-9', H-11' and H-12'), 2.79 (2H, t, J = 15 Hz, H-11'), 2.50 (2H, t, J = 7.5 Hz, H-1'), 194 
2.06 (4H, m, H-8' and H-14'), 1.57 (2H, brs, H-2'), 1.38 (approx. 14H, brs), 0.90 (3H, t, 195 
J = 6.9 Hz, H-17'). 13C NMR (125 MHz, CDC13): δ 156.8 (C-1 and C-3), 146.1 (C-5), 196 
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130.2/130.1 (C-12'/C-8'), 128.0/127.9 (C-9'/C-11'), 107.9 (C-4 and C-6), 100.2 (C-2), 197 
35.9 (C-l'), 31.5 (C-15'), 29.7-28.7 (multiple carbon signals), 27.25/27.22 (C-7'/C-13'), 198 
25.6 (C-10'), 24.86 (C-2'), 22.6 (C-16'), 14.1 (C-17'). 199 
Heterologous expression of SsARS in E. coli and S. cerevisiae and product analysis 200 
S. cerevisiae BJ5464/pHW8 was grown in 50 mL of Synthetic Complete (SC)-Ura 201 
medium at 28°C to an OD600 1.0, and then 50 mL of YP medium (1% yeast extract and 202 
2% peptone) was added. The broth was maintained at 28°C and 250 rpm for an 203 
additional 3 days. The fermentation broth was extracted and analyzed using the same 204 
method as described above. 205 
Results 206 
Phylogenetic analysis of SsARS from Shiraia sp. Slf14 207 
Annotation of the genome sequencing data of Shiraia sp. Slf14 led to the discovery of 208 
a putative type III PKS SsARS in scaffold 13. BLAST analysis showed that SsARS is 209 
homologous to a number of type III PKSs. A phylogenetic analysis of SsARS and nine 210 
known type III PKSs from fungi, plant and bacteria revealed that SsARS falls within a 211 
clade of type III PKSs, and it forms a separate subclade together with Neurospora 212 
crassa ORAS (Funa et al. 2007) and Sporotrichum laxum Sl-PKS2 (Sun et al. 2016). 213 
As shown in Fig. 1, the horizontal dimension gives the extent of genetic change, and it 214 
was found that SsARS are more similar to Sl-PKS2 and ORAS. Both Sl-PKS2 and 215 
ORAS were previously reported to synthesize fatty acid-primed resorcinols, suggesting 216 
that SsARS is likely an alk(en)ylresorcinol synthase (ARS). Sequence alignment 217 
revealed that SsARS has 34% identity with N. crassa ORAS and 36% identity with S. 218 
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laxum Sl-PKS2. SsARS maintains an identical CoA binding site with the reported type 219 
III PKSs and a conserved catalytic triad of Cys-153, His-308, and Asn-341 (numbering 220 
in SsARS). 221 
Heterologous expression of SsARS in E. coli BL21(DE3) and characterization of 222 
the polyketide products 223 
The 1,278-bp intron-free cDNA of Ssars was synthesized from mRNA through reverse 224 
transcription. The gene was ligated to the expression vector pET28a to yield pHW4. E. 225 
coli BL21(DE3) was transformed with pHW4 and cultured in LB broth and induced 226 
with 200 μM IPTG. After incubated at 28℃ and 250 rpm condition overnight, the cells 227 
were collected and lysed for SDS-PAGE analysis. Compared to E. coli BL21(DE3) 228 
harboring the empty vector pET28a, a protein band at ∼47 kDa was observed (Fig. 2A), 229 
suggesting that SsARS was successfully expressed in this heterologous host. We next 230 
examined whether this enzyme can generate any polyketide products in E. coli. The 231 
extracts of E. coli BL21(DE3)/pHW4 and E. coli BL21(DE3)/pET28a were analyzed 232 
by HPLC. As shown in Fig. 2B, BL21(DE3)/pHW4 produced a series of nonpolar 233 
products with retention times between 20 and 45 min (trace i), while the control with 234 
the empty vector did not have the same peaks. These six major products were numbered 235 
as 1-6. Therefore, through SDS-PAGE and HPLC analysis, we confirmed that SsARS 236 
were functionally expressed in E. coli BL21(DE3). 237 
Characterization of the six polyketide products from E. coli BL21(DE3)/pHW4 238 
To structurally characterize the six products, these compounds were isolated from the 239 
culture of E. coli BL21(DE3)/pHW4. Compounds 1-6 were obtained as yellowish oil. 240 
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These compounds were identified as alk(en)ylresorcinols with either an unsaturated or 241 
saturated aliphatic side chain (Fig. 2B) based on their UV, MS and NMR spectra and a 242 
comparison with previously published data (Suzuki et al. 1997 ). The molecular weights 243 
of 1-6 were determined to be 264, 290, 292, 318, 320 and 346 based on their [M+H]+ 244 
ion peaks at m/z 265.2, 291.2, 293.2, 319.2, 321.4 and 347.3 in the ESI-MS (Fig. 3A), 245 
respectively. Compounds 1, 3 and 5 were deduced to be alkylresorcinols with a 246 
saturated side chain, while 2, 4 and 6 have an unsaturated side chain. The 1H NMR 247 
spectrum of 1 revealed two aromatic proton signals at δH 6.26 (2H, d, J = 1.8 Hz, H-4 248 
and H-6) and δH 6.22 (1H, t, J = 1.8 Hz, H-2), suggesting that a resorcinol moiety is 249 
present in the structure. In addition, proton signals typical for a long aliphatic chain 250 
including the benzylic methylene at δH 2.49 (2H, t, J = 7.5 Hz) and terminal methyl 251 
group at δH 0.90 (3H, t, J = 6.9 Hz) were also found. Thus, 1 can be identified as 1,3-252 
dihydroxyphenyl-5-undecane (Fig. 3B). The NMR data of 3 and 5 are highly similar to 253 
those of 1, except that they have two and four more aliphatic proton signals, respectively. 254 
Accordingly, 3 was identified as 1,3-dihydroxyphenyl-5-tridecane and 5 was 255 
characterized as 1,3-dihydroxyphenyl-5-pentadecane (Fig. 3B).  256 
There are two aromatic proton signals at δH 6.26 (2H, d, J = 1.8 Hz, H-4 and H-6) 257 
and δH 6.20 (1H, t, J = 1.8 Hz, H-2) in the 
1H NMR spectrum of 2, indicating that a 258 
resorcinol moiety is also present in the structure. Similar to 1, proton signals for a long 259 
aliphatic chain including the benzylic methylene at δH 2.51 (2H, t, J = 7.5 Hz) and 260 
terminal methyl group at δH 0.92 (3H, t, J = 6.9 Hz) were also present. However, two 261 
overlapping olefinic protons at δH 5.38-5.36 indicated that there is a double bond in the 262 
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side chain. Thus, 2 was characterized as 1,3-dihydroxyphenyl-5-cis-6'-tridecene (Fig. 263 
3B). Similarly, 4 and 6 were identified as resorcinol derivatives containing an 264 
unsaturated C15 and C17 side chain, named 1,3-dihydroxyphenyl-5-cis-8'-pentadecene 265 
and 1,3-dihydroxyphenyl-5-cis-10'-heptadecene, respectively (Fig. 3B). Compounds 2, 266 
4 and 6 were previously isolated and characterized by our group from an engineered E. 267 
coli strain that expressed Sl-pks2 from the biosynthetic pathway in spirolaxine in 268 
Sporotrichum laxum ATCC 15155 (Sun et al. 2016). Overall, the MS and 1H NMR data 269 
of these known 5-alkenylresorcinols were consistent with our and others' reported data 270 
(Knodler et al. 2008; Sun et al. 2016; Suzuki et al. 1997 ).  271 
Effect of supplementation of exogenous fatty acids on the biosynthesis of 5-272 
alk(en)ylresorcinols 273 
While the fatty acyl side chains of 1-6 were believed to be from the corresponding fatty 274 
acyl starter units caught by SsARS from the biosynthetic or degradative pathways 275 
within E. coli cells, we next tested how supplementation of exogenous fatty acids 276 
affects the product profile in E. coli BL21(DE3)/pHW4. Soybean oil is known to 277 
contain various fatty acids. To this end, 20 g/L soybean oil was supplied into the culture 278 
medium. The extract was analyzed by HPLC, and a new product 7 at 33.2 min was 279 
observed (Fig. 4A). This compound has a typical UV spectrum of alkenylresorcinols 280 
(Fig. 4B), suggesting that 7 is a derivative of alk(en)ylresorcinol.  281 
Compound 7 was then isolated from the culture and subjected to MS and NMR 282 
analyses. The molecular weight of 7 was determined to be 344 based on the [M+H]+ 283 
ion peak at m/z 345.3 (Fig. 4C), which is two mass units less than 6, suggesting that an 284 
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additional double bond is present in the fatty acyl side chain of 7. The 1H NMR 285 
spectrum showed the three aromatic protons at δH 6.25 (H-4 and H-6) and 6.20 (H-2), 286 
benzylic methylene protons at δH 2.50 (H-1'), and terminal CH3 signal at δH 0.90 (H-287 
17'). Four overlapping olefinic proton signals were found at δH 5.34-5.41 and four 288 
corresponding carbon signals were found in the 13C NMR spectrum, including δC 130.2, 289 
130.1, 128.0 and 127.9, confirming that there are two double bonds in the side chain. 290 
By comparing the 1H and 13C NMR data with those of linoleic acid (C18:2 cis, cis-9,12-291 
octadecadienoic acid) (Bus and Frost 1976; Frost and Gunstone 1975; Glass and Dutton 292 
1964), compound 7 was identified as 5-(8'Z,11'Z-heptadecadienyl)resorcinol. 293 
We next compared the titers of compounds 1-7 in the cultures of E. coli 294 
BL21(DE3)/pHW4 with and without supplementation of soybean oil. As shown in Fig. 295 
4E, it is apparent that supply of soybean oil increased the production of 296 
alk(en)ylresorcinols. Additionally, compound 7 was only produced when soybean oil 297 
was added into the fermentation medium, indicating that the exogenously supplied fatty 298 
acids can be used by SsARS to generate the polyketide products.  299 
Heterologous expression of SsARS in S. cerevisiae BJ5464 and characterization of 300 
the polyketide products 301 
The intron-free gene of Ssars was ligated to the YEpADH2p-URA3 vector to yield a 302 
yeast expression plasmid pHW8, which was then expressed in S. cerevisiae BJ5464. 303 
HPLC analysis of the fermentation broth of S. cerevisiae BJ5464 revealed that the same 304 
set of alk(en)ylresorcinols 1-6 were produced (trace i, Fig. 5), while the strain harboring 305 
the empty YEpADH2p-URA3 vector did not produce these products. This result 306 
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confirmed that SsARS can also be functionally reconstituted in yeast and synthesize the 307 
same products as E. coli.  308 
Discussion 309 
Shiraia sp. Slf14 is an endophytic fungus from H. serrata. It was found to produce the 310 
medicinally important molecules (Yang et al. 2014). In this work, we found a putative 311 
type III PKS gene Ssars from the genome of this fungal strain and functionally 312 
expressed it in E. coli and S. cerevisiae. Expression of this enzyme in the two 313 
heterologous hosts led to the production of six major alk(en)ylresorcinols 1-6, which 314 
unambiguously confirmed that SsARS is a type III PKS that specifically synthesizes 315 
resorcinol derivatives with flexible substrate specificity toward the fatty acyl starter 316 
units (Fig. 3B). The thioesters of common fatty acids in E. coli (Mejía et al. 1999; Shaw 317 
and Ingraham 1965 ) and yeast (Khalilova et al. 2016; Lamacka et al. 1998) are 318 
proposed to be used by SsARS as the starter units to synthesize 1-6, with malonyl-CoA 319 
as the general substrate for polyketide chain elongation. Specifically, the thioesters of 320 
the unsaturated fatty acids including tetradecenoic acid (cis-7), hexadecenoic acid (cis-321 
9), and octadecenoic acid (cis-11) were used by SsARS to generate 2, 4 and 6, while 322 
the thioesters of myristic acid (C14:0), palmitic acid (C16:0) and stearic acid (C18:0) 323 
acted as the starter units to afford 1, 3 and 5, respectively (Fig. 3B). Fatty acid 324 
composition of soybean oil of 18 varieties in the United States was reported to contain 325 
about 5% to 11% in linolenic acid (C18:3), 43% to 56% in linoleic acid (C18:2), 15% 326 
to 33% in oleic acid (C18:1), as well as 11% to 26% in saturated acids such as 4% 327 
stearic and 10% palmitic acids (Collins and Sedgwick 1959). These fatty acids 328 
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apparently have contributed to the production of the corresponding alk(en)ylresorcinols, 329 
leading to the increased production of 1-6 and the biosynthesis of an additional product 330 
7 (from the major unsaturated fatty acid linoleic acid in soybean oil). This indicated 331 
that exogenous fatty acids can be used by the engineered E. coli strain to synthesize 332 
these alk(en)ylresorcinols.   333 
Compared to many other natural products, alk(en)ylresorcinols are relatively rare 334 
in nature, with the main known sources being wheat, rye, barley, triticale (cereal 335 
grasses), the fruit of Ginkgo biloba, a mollusc and some species of bacteria. The 336 
concentrations of alk(en)ylresorcinols are normally between 300 and 1500 μg/g in 337 
wheat and rye (Ross et al. 2004). Due to their almost exclusive presence in the outer 338 
part of wheat and rye grains among commonly consumed foods (Ross et al. 2003), 339 
alk(en)ylresorcinols have been suggested and evaluated as biomarkers of whole grain 340 
wheat and rye intake in different populations (Biskup et al. 2016; Kyro et al. 2014; 341 
Magnusdottir et al. 2014; McKeown et al. 2010; Wierzbicka et al. 2015). A recent 342 
research revealed the dual nature of alk(en)ylresorcinols, direct antioxidant properties 343 
and the ability to indirectly regulate the activity of cellular antioxidative defense 344 
mechanisms (Gryazeva et al. 2015). Discovery and heterologous reconstitution of 345 
SsARS in this work provides an efficient way to produce desired alk(en)ylresorcinols 346 
by supplying corresponding fatty acids.  347 
Conclusion 348 
In summary, we identified a new alk(en)ylresorcinol synthase SsARS from an 349 
endophytic fungal strain Shiraia sp. Slf14. This enzyme was functionally reconstituted 350 
17 
 
in both E. coli and S. cerevisiae. This fungal type III PKS showed relaxed substrate 351 
specificity toward endogenous and exogenous fatty acids. Depending on the availability 352 
of fatty acids in the cells or culture medium, different alk(en)ylresorcinols can be 353 
synthesized using this enzyme.   354 
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Figure legends 484 
Fig. 1. A phylogenetic tree of SsARS and nine known type III PKSs. The nine type 485 
III PKSs include CsyA from Aspergillus oryzae, GenBank accession no. BAD97390.1; 486 
CsyB from A. oryzae, GenBank accession no. BAD97391.1; CsyC from A. oryzae, 487 
GenBank accession no. BAD97392.1; CsyD from A. oryzae, GenBank accession 488 
no. BAD97394.1; DpgA from Streptomyces toyocaensis, GenBank accession 489 
no. Q8KLK5.1; OKS from Aloe arborescens, GenBank accession no. Q3L7F5.1; 490 
StTS from Streptomyces toxytricini, GenBank accession no. AEO44526.1; 491 
ORAS  from  Neurospora crassa, GenBank accession no. XP_960427.1; and Sl-492 
PKS2 from Sporotrichum laxum, GenBank accession no. AMW87980.1. 493 
Fig. 2. Heterologous reconstitution of SsARS in E. coli BL21(DE3). (A) SDS-PAGE 494 
analysis of the expression of SsARS in E. coli BL21(DE3). (B) HPLC analysis (at 210 495 
nm) of the polyketide metabolites produced by E. coli BL21(DE3)/pHW4. (i) Extract 496 
of E. coli BL21(DE3)/pHW4; (ii) Extract of E. coli BL21(DE3)/pET28a.  497 
Fig. 3. Structural characterization of 1-6. (A) The ESI-MS (+) spectra of 1-6. (B) 498 
Structures of compounds 1-6 and their biosynthetic pathway.  499 
Fig. 4. Precursor-directed biosynthesis of an alkylresorcinol product with soybean oil. 500 
(A) HPLC analysis (at 210 nm) of the extract of E. coli BL21(DE3)/pHW4 in LB 501 
supplemented with 2% soybean oil. (B) UV spectrum of 7. (C) ESI-MS (+) spectrum 502 
of 7. (D) Structure of 7. (E) The titers of 1-7 in the cultures of E. coli BL21(DE3)/pHW4 503 
in LB with or without soybean oil. Data were from three experiments and are shown as 504 
meanSD.   505 
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Fig. 5. HPLC analysis (at 210 nm) of the products synthesized by SsARS in the yeast. 506 
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